Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Indikator
Negara-negara
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Pendapatan
Liburan
Negara-negara
Amerika Serikat
Inggris Raya
Kawasan Euro
Australia
Kanada
Jepang
Tiongkok
Brazil
Rusia
India
Selanjutnya Negara-negara
Indikator
Tingkat Bunga
Tingkat Inflasi
Tingkat Pengangguran
Pertumbuhan PDB (q-to-q)
Pdb Per Kapita
Transaksi Berjalan
Cadangan Emas
Utang Pemerintah
Produksi Minyak Mentah
Harga Bensin
Peringkat Kredit
Selanjutnya Indikator
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Apps
App Store
Google Play
Twitter
Light
Dark
System
Akebia Therapeutics | AKBA - Pendapatan Penjualan
Keuangan
Harga Saham
USD 0.42
Aktiva
USD 342.13M
Kas Dan Setara
USD 159.25M
Biaya Penjualan
USD 10.34M
Aset Lancar
USD 220.79M
Kewajiban Lancar
USD 162.35M
UTANG
USD 46.51M
Dividen - Hasil
0
EBIT
USD -5.45M
EBITDA
USD 14.03M
Karyawan
167
Eps Laba Per Saham
USD -0.04
Modal Dan Cadangan
USD 20.37M
Laba Kotor Pada Penjualan
USD 47.28M
Beban Bunga Utang
342.13M
Modal Pinjaman
USD 12.78M
Kapitalisasi Pasar
USD 85.6M
Batas Pemasukan
USD -12.24M
Biaya Operasional
USD 63.08M
Laba Operasional
USD -5.45M
Modal Saham Biasa
USD 265.43M
Pe Harga Untuk Laba
1.63K
Laba Sebelum Pajak
USD -11.24M
Pendapatan Penjualan
USD 57.62M
Beban Penjualan Dan Administrasi
USD 23.53M
Saham
USD 18.7M
Kreditur Perdagangan
USD 7.61M
Debitur Perdagangan
USD 47.03M
Penjualan
Perubahan
Tanggal
Acadia Pharmaceuticals
USD 342M
34.04M
2026-09
Agios Pharmaceuticals
USD 55.38M
10.64M
2026-09
Akebia Therapeutics
USD 57.62M
1.14M
2025-12
Alnylam Pharmaceuticals
USD 1.46B
170M
2026-09
Amgen
USD 10.4B
300M
2026-09
Ardelyx
USD 120.88M
26.41M
2026-06
Astellas Pharma
JPY 629.95B
10.96B
2026-09
AstraZeneca
USD 16.21B
830M
2026-09
Bayer
EUR 10.05B
820M
2026-09
BioMarin Pharmaceutical
USD 1.03B
40M
2026-09
Celltrion
KRW 1.24T
90B
2026-06
Cspc Pharmaceutical
CNY 6.47B
355.1M
2026-03
Deva Holding AS
TRY 2.32B
418.58M
2023-09
Dianthus Therapeutics
USD 761K
298K
2026-06
Exelixis
USD 658.69M
30M
2026-09
Fresenius Medical Care
EUR 4.94B
80M
2026-09
GlaxoSmithKline
GBP 8.89B
480M
2026-09
Ionis Pharmaceuticals
USD 243M
25M
2026-09
Ironwood Pharmaceuticals
USD 113.04M
6.53M
2026-06
J&J
USD 25.4B
89M
2026-09
Kangmei Pharma
CNY 1.19B
106M
2026-06
Karyopharm Therapeutics
USD 35.07M
987K
2026-03
Knight Therapeutics
CAD 133.11M
11.56M
2025-12
Laboratorios Farma
EUR 448.66M
67.82M
2023-12
Lexicon Pharmaceuticals
USD 5.49M
8.69M
2025-12
Medical Developments International
AUD 21.57M
12.04M
2025-12
Moderna
USD 1.31M
98.69M
2026-09
Nektar Therapeutics
USD 10.86M
10.95M
2026-03
Neuren Pharmaceuticals
AUD 42.24M
28.1M
2025-12
Organigram Holdings
CAD 105.78M
45.99M
2026-06
Pharma Mar
EUR 54.2M
4.2M
2026-09
Prothena
USD 1.01M
50.07M
2026-06
PTC Therapeutics
USD 357.8M
3.2M
2026-09
Qiagen NV
USD 487.78M
24.66M
2026-09
Regeneron Pharmaceuticals
USD 5.12B
830M
2026-09
Roche Holding
CHF 30.36B
14.71B
2026-06
Sanofi
EUR 14.44B
2.49B
2026-09
Sarepta Therapeutics
USD 381.4M
19.9M
2026-09
Sartorius
EUR 926.3M
14.5M
2026-09
Sino Biopharmaceutical
CNY 19.44B
5.18B
2026-06
Tectonic Therapeutic
USD 0
0
2024-12
Tilray
USD 217.51M
74.75M
2025-12
Vanda Pharmaceuticals
USD 198.77M
151.12M
2024-12
Zealand Pharma A/S
34M
34.92M
2026-03
Zhangzhou Pientzehuang Pharmaceutical
CNY 1.78B
50M
2026-09
×